23mofang
23魔方 is a Chinese consumer DNA testing brand offering saliva-based genetic tests covering ancestry, health, and traits for Chinese users.
Last updated October 9, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
23魔方 (Chengdu 23mofang Biotechnology Co., Ltd.) was established in March 2015 and provides genetic testing services for Chinese people, along with life-data analysis. Its consumer DNA test uses a saliva sample and covers hundreds of items across categories such as ancestry analysis, genetic risk, genetic traits, carrier status, nutritional needs, drug response, sports health, and skin management. The company operates its own testing center certified to clinical medical laboratory standards and states it has collaborated with institutions including Fudan University's Key Laboratory of Modern Anthropology, the Medical Genetics Center of the First Affiliated Hospital of Army Medical University, and the Kunming Institute of Zoology, CAS. According to the company, it ranked first in the consumer genetic testing industry per Analysys's 2018 China genetic testing industry analysis, and was listed by Forbes China among China's 50 most innovative companies.
History
Chengdu 23mofang Biotechnology Co., Ltd. was established in March 2015 and provides genetic testing services for Chinese people while conducting life-data analysis. The company name '23魔方' derives from humans having 23 pairs of chromosomes, with '魔方' (Rubik's cube) expressing the polymorphism of genes. It builds its business on an internet-plus-genetic-testing model and a life-science big-data database, with the stated mission of 'digitizing life so everyone benefits.' Since its founding it has accumulated six rounds of financing, with investors including SoftBank China, Hanwang Technology, Matrix Partners China, and Chende Capital; disclosed rounds include an angel round in April 2015, Pre-A in January 2016, A in January 2017, B in August 2017, B+ in March 2018, and B3 in May 2018.
- 2018
Series B+ financing, with Jingwei China, Yahui Medical, Hanwang Technology, and Deshang Qidian as investors.
- 2018
Series B3 financing, with Chende Capital, SoftBank China, Jingwei China, Bencao Capital, and Yahui Medical as investors.
- 2018
According to the 'China Genetic Testing Industry Analysis 2018' released by Analysys, 23mofang ranks first in the consumer genetic testing industry.
- 2018
23mofang is listed in Forbes China's '50 Most Innovative Companies in China' and is praised by Forbes China as a 'Genetic Testing Innovator'.
- 2017
Series A financing, with Yahui Medical and Hanwang Qichuang as investors.
- 2017
Series B financing, with Hanwang Technology, Yahui Medical, Fenghou Capital, and Deshang Qidian as investors.
- 2016
Pre-A round of financing, with Qidian Capital and Feng Hou Capital as investors.
- 2015
Chengdu 23mofang Biotechnology Co., Ltd. is established in March 2015, offering genetic testing services for Chinese people and conducting life data analysis.
- 2015
Angel round of financing, with Feng Hou Capital as investor.
Products and positioning
Consumer-facing genetic testing for Chinese users, built on an internet-plus-genetic-testing model and a life-science big-data database.
23魔方 personal genetic test
Saliva-based consumer DNA test covering hundreds of items across ten categories, including ancestry, physiological traits, and genetic risk.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/23mofang-co-ltd · Editorial policy · How profiles are compiled